Boule Diagnostics Balance Sheet Health
Financial Health criteria checks 3/6
Boule Diagnostics has a total shareholder equity of SEK254.9M and total debt of SEK163.9M, which brings its debt-to-equity ratio to 64.3%. Its total assets and total liabilities are SEK538.5M and SEK283.6M respectively.
Key information
64.3%
Debt to equity ratio
SEK 163.90m
Debt
| Interest coverage ratio | n/a |
| Cash | SEK 17.20m |
| Equity | SEK 254.90m |
| Total liabilities | SEK 283.60m |
| Total assets | SEK 538.50m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 8BD's short term assets (SEK229.9M) exceed its short term liabilities (SEK221.7M).
Long Term Liabilities: 8BD's short term assets (SEK229.9M) exceed its long term liabilities (SEK61.9M).
Debt to Equity History and Analysis
Debt Level: 8BD's net debt to equity ratio (57.6%) is considered high.
Reducing Debt: 8BD's debt to equity ratio has increased from 27.6% to 64.3% over the past 5 years.
Debt Coverage: 8BD's debt is well covered by operating cash flow (37%).
Interest Coverage: Insufficient data to determine if 8BD's interest payments on its debt are well covered by EBIT.